Literature DB >> 32221546

Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia.

Luisa Agnello1, Giulia Bivona1, Elisa Parisi2, Giuseppe Dejan Lucido3, Alessandro Iacona4, Anna Maria Ciaccio5, Rosaria Vincenza Giglio4, Ottavio Ziino2, Marcello Ciaccio1,4.   

Abstract

OBJECTIVE: In this study, we investigated the roles of presepsin (PSP) and midregional proadrenomedullin (mr-proADM) in children with febrile neutropenia (FN) due to chemotherapy.
METHODS: We assessed 36 FN episodes in 26 children. Patients were classified into bacteremia (B) and fever of unknown origin (FUO) groups. We evaluated PSP and mr-proADM at admission (T0), after 24/48 h (T1), and after 5 days (T2).
RESULTS: PSP and mr-proADM levels were elevated at T0 and significantly decreased at T2. mr-proADM levels did not significantly differ between the B and FUO groups. PSP levels significantly differed between the B and FUO groups only at T1. Both PSP and mr-proADM levels at T0 were a predictor of length of hospital stay but not of the duration of fever. Finally, receiver operating characteristic curve analysis showed that PSP and mr-proADM had low diagnostic accuracy for blood culture positivity.
CONCLUSION: PSP and mr-proADM display poor clinical usefulness for FN in oncologic children. © American Society for Clinical Pathology 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Adrenomedullin; Presepsin; fever; malignancies; mr-proADM; neutropenia; oncologic; pediatric

Mesh:

Substances:

Year:  2020        PMID: 32221546     DOI: 10.1093/labmed/lmaa011

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  2 in total

Review 1.  A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker.

Authors:  Anna Solé-Ribalta; Sara Bobillo-Pérez; Iolanda Jordan-García
Journal:  Children (Basel)       Date:  2022-08-06

2.  Clinical Analysis of Severe Radiation Pneumonia.

Authors:  Feng-Jiang Li; Xin Yuan; Cheng Chen; Min-Li Zhu; Chang-Qing Bai; Rui-Juan Wang
Journal:  Int J Gen Med       Date:  2021-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.